A Clinical Study of T3011 in Subjects With Advanced Melanoma
Conditions: Advanced Melanoma Interventions: Biological: T3011 Sponsors: Shanghai Pharmaceuticals Holding Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Allogeneic Gammadelta T Cells Combined With Interferon- α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
Conditions: Melanoma Interventions: Biological: Ex-vivo expanded allogeneic γδ T cells; Drug: Recombinant human interferon α1b; Drug: Pembrolizumab Sponsors: Xijing Hospital; Beijing GD Initiative Cell Therapy Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Conditions: Locally Recurrent Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Squamous Cell Carcinoma; Refractory Head and Neck Squamous Cell Carcinoma Interventions: Drug: Losartan; Biological: Pembrolizumab; Radiation: Stereotactic Body Radiation Therapy Sponsors: Shyam S.D. Rao; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Conditions: Advanced Solid Tumor (Phase 1); Pancreas Adenocarcinoma; Non-small Cell Lung Cancer; Malignant Melanoma (Cutaneous) Interventions: Drug: IMM-6-415 Sponsors: Immuneering Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery
Conditions: Skin Cancer; Skin Cancer Face; Malignant Cutaneous Adnexal Neoplasm Interventions: Other: Povidone-Iodine Swabs; Diagnostic Test: Staphylococcus nasal swab; Drug: Antibiotic Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients
Conditions: Melanoma; PET CT Interventions: Diagnostic Test: additional PET/CT at 4 weeks, analysing using quantative analysis Sponsors: Institute of Oncology Ljubljana Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Prospective Randomized Phase III Study Evaluating Induction Chemotherapy (Modified DCF) Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced Anal Squamous Cell Carcinoma (T3-4 or N1a, b or c)
Conditions: Anal Cancer Interventions: Drug: induction chemotherapy (mDCF); Drug: Concomitant chemotherapy (Capecitabin + Mitomycin-C); Radiation: radiotherapy Sponsors: Federation Francophone de Cancerologie Digestive; Fondation ARCAD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
AMT-253 in Patients With Advanced Solid Tumours
Conditions: Malignant Melanoma; Advanced Solid Tumors Interventions: Drug: AMT-253 for injection Sponsors: Multitude Therapeutics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
A Phase 1/2a Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Conditions: Advanced Solid Tumor (Phase 1); Pancreas Adenocarcinoma; Non-small Cell Lung Cancer; Malignant Melanoma (Cutaneous) Interventions: Drug: IMM-6-415 Sponsors: Immuneering Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
Conditions: Head and Neck Cancer Interventions: Drug: Toripalimab; Radiation: Radiation Therapy; Drug: Cisplatin Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis
Conditions: Diarrhea; Colitis; Malignant Melanoma; Kidney Cancer Interventions: Procedure: Faecal Microbiota Transplantation (FMT); Procedure: Placebo Sponsors: University of Aarhus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
Conditions: Melanoma Stage III; Melanoma Stage IV; Melanoma Interventions: Biological: ADP-TILIL7; Drug: Cyclophosphamide; Drug: Fludarabine Phosphate; Drug: Proleukin Sponsors: Inge Marie Svane; Adaptimmune Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).
Conditions: Primary Squamous Cell Carcinoma of the Vulva; Recurrent Squamous Cell Carcinoma of the Vulva Interventions: Device: DaRT seeds Sponsors: Alpha Tau Medical LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Adebrelimab and dalpiciclib Sponsors: Zhongzheng Xiang Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Cancer; Cytokine Interventions: Other: Biopsies and Blood collection Sponsors: Poitiers University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
